Pacific Edge capital raise over-full

  Cancer diagnostics company Pacific Edge has made a well oversubscribed capital raise. It targeted a raise of $31.4m, at $0.17 per share, based on a NZ$25.4m placement and a $6m retail offer, with the ability to accept over-subscriptions at PEB’s discretion. The Retail Offer closed on May 28 2026, with total applications for $46.0m […]